resveratrol → miR-21 → disease activity

• Aberrant expression of miR-21 in patients with inflammatory bowel disease

  B→C
  Medicine (Baltimore)· 2020· PMID 32332611· doi
• Resveratrol Inhibits ROS‐Promoted Activation and Glycolysis of Pancreatic Stellate Cells via Suppression of miR‐21

  A→B
  Oxid Med Cell Longev· 2018· PMID 29854071· doi

Each row is one structured triple extracted by deepseek-v4-flash (prompt v1_2026_05_07, source: configured). Confidence is the LLM's self-rating.

• ResveratroldownregulatesmiR-21A→B
  "in activated pancreatic stellate cells"confidence 0.90· extraction run #17· claim #62966
• miR-21correlates_withdisease activityB→C
  "in ulcerative colitis patients"confidence 0.85· extraction run #31· claim #235133
• miR-21correlates_withdisease activityB→C
  "in Crohn disease patients"polarity: negativeconfidence 0.85· extraction run #31· claim #235134

No claims match this filter.

edge_support_log_ab

log(ab + 1) = 0.693

edge_support_log_bc

log(bc + 1) = 1.099

novelty_factor

1.000 (no direct drug→outcome evidence — full novelty)

direct_a_to_c_count

0

Embeddings are used at the L1 filtering stage to prune off-topic abstracts before claim extraction. They do not directly score the hypothesis.

model

bge-m3

dim

1024

max_length

8192 tokens

similarity_scores

No per-hypothesis cosine scores stored.

method

swanson_abc_log_evidence_with_novelty_penalty

formula

score = min((log(ab+1) + log(bc+1)) * novelty / 10, 1.0); novelty = 1.0 if direct==0 else 0.7 / (direct+1)

raw score

0.1792

outreach score

0.2688

quality tier

mid